| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.006 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.009 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |